Characterization of a unique anti-DNA hybridoma

Hybridoma

Volumn 17, Issue 1, 1998, Pages 33-40

  Blatt, Neal B ^a   Bill, Roslyn M ^a   Glick, Gary D ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA ANTIBODY; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; MONOCLONAL ANTIBODY;

AMINO ACID SEQUENCE; ANIMAL CELL; ANTIBODY PRODUCTION; ARTICLE; CELL FUSION; CHROMOSOME NUMBER; CONTROLLED STUDY; DNA BINDING; DNA SEQUENCE; FLOW CYTOMETRY; GENE EXPRESSION; HYBRIDOMA; MOLECULAR CLONING; MOUSE; MYELOMA CELL; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SPLEEN CELL;

ANIMALIA;

EID: 0031932230     PISSN: 0272457X     EISSN: None     Source Type: Journal    
DOI: 10.1089/hyb.1998.17.33     Document Type: Article

References (46)

1. Köhler G, and Milstein C: Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 1975;256:495-497.
2. Bartal AH and Hirshaut Y: Methods of Hybridoma Formation. Humana Press: Clifton, NJ, 1987;pp. 1-40.
3. Roark JH, Kuntz CL, Nguyen K-A, Mandik L, Cattermole M, and Erikson J: B cell selection and allelic exclusion of an anti-DNA Ig transgene in MRL-lpr/lpr mice. J Immunol 1995;154:4444-4455.
4. Zack DJ, Wong AL, Stempniak M, and Weisbart RH: Two kappa immunoglobulin light chains are secreted by an anti-DNA hybridoma: Implications for isotypic exclusion. Mol Immunol 1995; 32:1345-1353.
5. Taggart RT, and Samloff IM: Stable antibody-producing murine hybridomas. Science 1983;219:1228-1230.
6. Swanson PC, Ackroyd C, and Glick GD: Ligand recognition by anti-DNA autoantibodies. Affinity, specificity, and mode of binding. Biochemistry 1996;35:1624-1633.
7. Swanson PC, Yung RL, Blatt NB, Eagan MA, Norris JN, Richardson BC, Johnson KJ, and Glick GD: Ligand recognition by murine anti-DNA autoantibodies. II. Genetic Analysis and Pathogenicity. J Clin Invest 1996;97:1748-1760.
8. Shulman M, Wilde CD, and Köhler G: A better cell line for making hybridomas secreting specific antibodies. Nature 1978;276: 269-270.
9. Kearney JF, Radbruch A, Liesegang B, and Rajewsky K: A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines. J Immunol 1979;123:1548-1550.
10. Barch MJ: The ACT Cytogenetics Laboratory Manual, 2nd ed. Raven Press, New York, 1991.
11. Coloma MJ, Hastings A, Wims LA, and Morrison SL: Novel vectors for the expression of antibody molecules using variable regions generated by polymerase chain reaction. J Immunol Methods 1992;152:89-104.
12. Kabat EA, Wu TT, Perry HM, Gottesman KS, and Foeller C: Sequences of Proteins of Immunological Interest, 5th ed.; U.S Department of Health and Human Services, Public Health Service, National Institutes of Health, 1991.
13. Coligan JE, Dunn BM, Pleogh HL, Speicher DW, and Wingfield PT: Current Protocols in Protein Science. Wiley, New York, 1995.
14. Cabilly S, and Riggs AD: Immunoglobulin transcripts and molecular history of a hybridoma that produces antibody to carcinoembryonic antigen. Gene 1985;40:157-161.
15. Carroll WL, Mendel E, and Levy S: Hybridoma fusion cell lines contain an aberrant kappa transcript. Mol Immunol 1988;25:991-995.
16. Kleymann G, Ostermeier C, Ludwig B, Skerra A, and Michel H: Engineered Fv fragments as a tool for the one-step purification of integral multisubunit membrane protein complexes. Bio/Technology 1995;13:155-160.
17. Leahy DJ, Rule GS, Whittaker MM, and McConnell HM: Sequences of 12 monoclonal anti-dinitrophenyl spin-label antibodies for NMR studies. Proc Natl Acad Sci USA 1988;85:3661-3665.
18. Strohal R, Kroemer G, Wick G, and Kofler R: Complete variable region sequence of a nonfunctionally rearranged kappa light chain transcribed in the nonsecretor P3-X63-Ag8.653 myeloma cell line. Nucleic Acids Res 1987;15:2771.
19. Hengartner H, Meo T, and Müller E: Monoclonal Antibodies. Hybridomas: A New Dimension in Biological Analyses; Plenum Press, New York, 1980; pp. 61-71.
20. Davie JM, Paul WE, Mage RG, and Goldman ME: Membrane-associated immunoglobulin of rabbit peripheral blood lymphocytes: Allelic exclusion at the b locus. Proc Natl Acad Sci USA 1971;68: 430-434.
21. Morse III HC, Neiders ME, Lieberman R, Lawton III AR, and Asofsky R: Murine plasma cells secreting more than one class of immunoglobulin heavy chain. II. SAMM 368 - A plasmacytoma secreting IgG2b-κ and IgA-κ immunoglobulins which do not share idiotypic determinants. J Immunol 1977;118:1682-1689.
22. Loor F, and Kelus AS: Allelic exclusion in the B lineage cells of the rabbit. Eur J Immunol 1978;8:315-324.
23. Kwan S-P, Max EE, Seidman JG, Leder P, and Scharff MD: Two kappa immunoglobulin genes are expressed in the myeloma S107. Cell 1981;26:57-66.
24. Tsukamoto A, Weissman IL, and Hunt SV: Allelic exclusion in rat kappa immunoglobulin chains: extent of Jκ rearrangement in normal lumphocytes. EMBO J 1984;3:975-981.
25. Wabl MR, Beck-Engeser G, and Burrows PD: Allelic inclusion in the pre-B-cell line 18-81. Proc Natl Acad Sci USA 1984;81:867-870.
26. Beck-Engeser G, Jäck H-M, and Wabl M: Allelic inclusion in a pre-B-cell line that generates immunoglobulin heavy chain genes in vitro. Proc Natl Acad Sci USA 1987;84:1060-1064.
27. Cherepakhin VV, Jackubov LZ, Ibraghimov AR, and Rokhlin OV: Allelic exclusion frequency analysis and molecular characteristics of immunoglobulins secreted by the hybridomas expressing both allelic genes. Immunol Lett 1987;15:33-39.
28. Picarella D, Serunian LA, and Rosenberg N: Allelic exclusion of membrane but not secreted immunoglobulin in a mature B cell line. Eur. J Immunol 1991;21:55-62.
29. Rassenti LZ, and Kipps TJ: Lack of allelic exclusion in B cell chronic lymphocytic leukemia. J Exp Med 1997;185:1435-1445.
30. Rimm IJ, Bloch DB, and Seidman JG: Allelic exclusion and lymphocyte development. Lessons from transgenic mice. Mol Biol Med 1989;6:355-364.
31. Costa TEF, Suh H, and Nussenzweig MC: Chromosomal position of rearranging gene segments influences allelic exclusion in transgenic mice. Proc Natl Acad Sci USA 1992;89:2205-2208.
32. Iliev A, Spatz L, Ray S, and Diamond B: Lack of allelic exclusion permits autoreactive B cells to escape detection. J Immunol 1994; 153:3551-3556.
33. Spatz L, Saenko V, Iliev A, Jones L, Geskin L, and Diamond B: Light chain usage in anti-double-stranded DNA B cell subsets: Role in cell fate determination. J Exp Med 1997;185:1317-1326.
34. Milstein C, and Cuello AC: Hybrid hybridomas and their use in immunohistochemistry. Nature 1983;305:537-540.
35. Staerz UD, and Bevan MJ: Hybrid hybridoma producing a bispecific monoclonal antibody that can focus effector T-cell activity. Proc Natl Acad Sci USA 1986;83:1453-1457.
36. Karawajew L, Behrsing O, Kaiser G, and Micheel B: Production and ELISA application of bispecific antibodies against fluorescein isothiocyanate (FITC) and horseradish peroxidase (HRP). J Immunol Methods 1988;111:95-99.
37. De Lau WBM, Heije K, Neefjes JJ, Oosterwegel M, Rozemuller E, and Bast BJEG: Absence of preferential homologous H/L chain association in hybrid hybridomas. J Immunol 1991;146:906-914.
38. De Lau WBM, Boom SE, Heije K, Griffioen AW, Braakman E, Bolhuis RLH, Tax WJM, Clevers H, and Bast BJEG: Heterodimeric complex formation with CD8 and TCR by bispecific antibody sustains paracrine IL-2-dependent growth of CD3+ CD8+ T cells. J Immunol 1992;149:1840-1846.
39. Kontsekova E, Kolcunova A, and Kontsek P: Quadroma-secreted bi(interferon alpha 2 - peroxidase) specific antibody suitable for one-step immunoassay. Hybridoma 1992;11:461-468.
40. Massino YS, Kizim EA, Dergunova NN, Vostrikov VM, and Dmitriev AD: Construction of a quadroma to α-endorphin/horseradish peroxidase using an actinomycin D-resistant mouse myeloma cell line. Immunol Lett 1992;33:217-222.
41. Massino YS, Dergunova NN, Kizim EA, Smimova MB, Tereshkina EB, Kolyaskina GI, and Dmitriev AD: Quantitative analysis of the products of IgG chain recombination in hybrid hybridomas based on affinity chromatography and radioimmunoassay. J Immunol Methods 1997;201:57-66.
42. Smith W, Jarrett AL, Beattie RE, and Corvalan JRF: Immunoglobulins secreted by a hybrid-hybridoma: Analysis of chain assemblies. Hybridoma 1992;11:87-98.
43. Shen G-L, Li J-L, and Vitetta ES: Bispecific anti-CD22/anti-CD3-ricin chain immunotoxin is cytotoxic to daudi lymphoma cells but not T cells in vitro and shows both A-chain-mediated and LAK-T-mediated killing. J Immunol 1994;152:2368-2376.
44. Ferrini S, Cambiaggi A, Sforzini S, Canevari S, Mezzanzanica D, Colnaghi MI, and Moretta L: Use of anti-CD3 and anti-CD16 bispecific monoclonal antibodies for the targeting of T and NK cells against tumor cells Cancer Det Prev 1993;17:295-300.
45. Kranenborg MHGC, Boerman OC, Oosterwijk-Wakka JC, de Weijert MCA, Corstens FHM, and Oosterwijk E: Development and characterization of anti-renal cell carcinoma X antichelate bispecific monoclonal antibodies for two-phase targeting of renal cell carcinoma. Cancer Res 1995;55:5864s-5867s.
46. Lindhofer H, Mocikat R, Steipe B, and Thierfelder S: Preferential species-restricted heavy/light chain pairing in rat/mouse quadromas. Implication for a single-step purification of bispecific antibodies. J Immunol 1995;155:219-225.